Blockade of peripheral nociceptive signal input relieves the formation of spinal central sensitization and retains morphine efficacy in a neuropathic pain rat model
Blockade of peripheral nociceptive signal input relieves the formation of spinal central sensitization and retains morphine efficacy in a neuropathic pain rat model
复制标题
阻断外周伤害性信号输入可减轻脊髓中枢敏化的形成并保留吗啡在神经性疼痛大鼠模型中的功效
DOI:
10.1016/j.neulet.2019.134643
复制
发表时间:
2019-11
影响因子:
2.5
通讯作者:
Xu Tao
中科院分区:
文献类型:
--
作者:
Zhong Wenhui;Ma Xiaqing;Xing Yuna;Kim Dong Kwan;Wang Aizhong;Jiang Wei;Xu Tao
Neural plasticity, especially central sensitization, is essential for developing and maintaining neuropathic pain. Unfortunately, the analgesic potency of morphine is greatly reduced in animal models and patients with neuropathic pain. We hypothesized that pre-activation of spinal N-methyl-d-aspartate receptors (NMDARs) by agonist or neuropathic pain facilitated the development of morphine-induced analgesic tolerance. We therefore investigated the effects of spinal NMDAR activation, induced by neuropathic pain, on the development of morphine-induced analgesic tolerance in male Sprague-Dawley rats. Four days of chronic constriction injury (CCI) induced upregulation of spinal NR1. Once established, spinal central sensitization accelerated the development of morphine-induced analgesic tolerance. Continuous ropivacaine infusion prevented CCI-induced increases in spinal Substance P (SP), NR1, and TRPV1. Blockade of peripheral nociceptive inputs prevented chronic morphine-induced increases in spinal SP, NR1, and TRPV1 and a rightward shift of the morphine dose-response curve in the CCI model. These findings suggest that pre-activation of spinal NMDARs contributes to central sensitization and potentiates the development of morphine-induced analgesic tolerance. Interruption of the peripheral nociceptive inputs during the induction phase could prevent spinal central sensitization and retain morphine efficacy, thereby delaying the development of morphine-induced tolerance in patients with neuropathic conditions.
登录
查看更多内容
影响因子:
8.8
作者:
Roh, Dae-Hyun;Kim, Hyun-Woo;Lee, Jang-Hern
通讯作者:
Lee, Jang-Hern
DOI:
10.1111/j.1526-4637.2009.00588.x
发表时间:
2009-04
期刊:
Pain medicine (Malden, Mass.)
影响因子:
--
作者:
Yawn BP;Wollan PC;Weingarten TN;Watson JC;Hooten WM;Melton LJ 3rd
通讯作者:
Melton LJ 3rd
DOI:
10.1016/j.ejps.2016.03.019
发表时间:
2016-09
期刊:
European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences
影响因子:
--
作者:
W. Ochiai;M. Kaneta;Marina Nagae;Ami Yuzuhara;Xin Li;Haruka Suzuki;Mika Hanagata;S. Kitaoka;Wataru Suto;Yoshiki Kusunoki;R. Kon;Kazuhiko Miyashita;D. Masukawa;N. Ikarashi;M. Narita;Tsutomu Suzuki;K. Sugiyama
通讯作者:
W. Ochiai;M. Kaneta;Marina Nagae;Ami Yuzuhara;Xin Li;Haruka Suzuki;Mika Hanagata;S. Kitaoka;Wataru Suto;Yoshiki Kusunoki;R. Kon;Kazuhiko Miyashita;D. Masukawa;N. Ikarashi;M. Narita;Tsutomu Suzuki;K. Sugiyama
影响因子:
7.4
作者:
Charles A. Warwick;L. Shutov;A. Shepherd;D. Mohapatra;Y. Usachev
通讯作者:
Charles A. Warwick;L. Shutov;A. Shepherd;D. Mohapatra;Y. Usachev
影响因子:
16.6
作者:
Marrone MC;Morabito A;Giustizieri M;Chiurchiù V;Leuti A;Mattioli M;Marinelli S;Riganti L;Lombardi M;Murana E;Totaro A;Piomelli D;Ragozzino D;Oddi S;Maccarrone M;Verderio C;Marinelli S
通讯作者:
Marinelli S